Sublingual immunotherapy (SLIT) with grass pollen allergen for grasspollen induced rhinoconjunctivitis in children.
- Registration Number
- NL-OMON23382
- Lead Sponsor
- Artu Biologicals Europe B. V, Lelystad, The Netherlands
- Brief Summary
J Allergy Clin Immunol. 2007 Apr;119(4):892-8. Epub 2007 Feb 23.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 204
1. Age; between 6 and 18 years;
2. Patients known in general practice with documented clinical history of grass pollen allergy with moderate disease intensity as retrospectively derived from the use of symptomatic allergy medication during the previous grass pollen season, i.e. regular use of cromoglycates as nasal spray and/or eye drops, and/or regular use of anti-histamine tablets or sprays and/or limited use of local acting or systemically administered corticosteroids;
1. Clinical history of severe asthmatic symptoms requiring inhalant therapy with daily pulmonary steroids during at least 3 months a year;
2. Allergic sensitivity to epithelial, in case the domestic animal is present in the family home;
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method